Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,424
archived clinical trials in
Cognitive Studies

Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Baylor Medical Center at Garland
1734
mi
from 98109
Garland, TX
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Baylor Medical Center at Garland
1734
mi
from 98109
Garland, TX
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Breast Care Center at Baylor College of Medicine/Methodist Hospital
1892
mi
from 98109
Houston, TX
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Breast Care Center at Baylor College of Medicine/Methodist Hospital
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
The University of Texas M. D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
The University of Texas M. D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Joe Arrington Cancer Research and Treatment Center
1439
mi
from 98109
Lubbock, TX
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Joe Arrington Cancer Research and Treatment Center
1439
mi
from 98109
Lubbock, TX
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Southwest Cancer Center
1440
mi
from 98109
Lubbock, TX
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Southwest Cancer Center
1440
mi
from 98109
Lubbock, TX
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Baylor Regional Medical Center
1669
mi
from 98109
Plano, TX
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Baylor Regional Medical Center
1669
mi
from 98109
Plano, TX
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Scott & White Hospital
1740
mi
from 98109
Temple, TX
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Scott & White Hospital
1740
mi
from 98109
Temple, TX
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Huntsman Cancer Institute at University of Utah
702
mi
from 98109
Salt Lake City, UT
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Huntsman Cancer Institute at University of Utah
702
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Danville Hematology & Oncology
2295
mi
from 98109
Danville, VA
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Danville Hematology & Oncology
2295
mi
from 98109
Danville, VA
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Olympic Hematology and Oncology Associates
13
mi
from 98109
Bremerton, WA
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Olympic Hematology and Oncology Associates
13
mi
from 98109
Bremerton, WA
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Benaroya Research Institute at Virginia Mason
1
mi
from 98109
Seattle, WA
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Benaroya Research Institute at Virginia Mason
1
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Swedish Medical Center
2
mi
from 98109
Seattle, WA
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Fred Hutchinson Cancer Research Center
0
mi
from 98109
Seattle, WA
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Fred Hutchinson Cancer Research Center
0
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Yakima Valley Memorial Hospital North Star Lodge Cancer Center
111
mi
from 98109
Yakima, WA
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Yakima Valley Memorial Hospital North Star Lodge Cancer Center
111
mi
from 98109
Yakima, WA
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Marshfield Clinic
1542
mi
from 98109
Marshfield, WI
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Marshfield Clinic
1542
mi
from 98109
Marshfield, WI
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Tom Baker Cancer Centre
440
mi
from 98109
Calgary,
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Tom Baker Cancer Centre
440
mi
from 98109
Calgary,
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Metro-Minnesota
1388
mi
from 98109
Saint Louis Park, MN
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Metro-Minnesota
1388
mi
from 98109
Saint Louis Park, MN
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Alvin J Siteman Cancer Center at Barnes-Jewish Hosp & Washington U Sch of Med
1717
mi
from 98109
Saint Louis, MO
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Alvin J Siteman Cancer Center at Barnes-Jewish Hosp & Washington U Sch of Med
1717
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Missouri Baptist Medical Center
1709
mi
from 98109
Saint Louis, MO
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Missouri Baptist Medical Center
1709
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated:  12/31/1969
Wilford Hall Medical Center
1783
mi
from 98109
Lackland Air Force Base, TX
Cognition in the Study of Tamoxifen and Raloxifene
Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene
Status: Enrolling
Updated: 12/31/1969
Wilford Hall Medical Center
1783
mi
from 98109
Lackland Air Force Base, TX
Click here to add this to my saved trials
Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose Using Positron Emission Tomography (PET) Scanning
Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose in Subjects With Varying Risk Factors for Alzheimer's Disease and Subjects on a Ketogenic Diet
Status: Enrolling
Updated:  12/31/1969
Wake Forest School of Medicine
2279
mi
from 98109
Winston-Salem, NC
Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose Using Positron Emission Tomography (PET) Scanning
Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose in Subjects With Varying Risk Factors for Alzheimer's Disease and Subjects on a Ketogenic Diet
Status: Enrolling
Updated: 12/31/1969
Wake Forest School of Medicine
2279
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
Hip Fracture Exercise and Rehabilitation Post Hip Fracture Study
Feasibility of Extended Post-Acute Intervention for Hip Fracture Patients With Cognitive Limitations: Hip Fracture Exercise and Rehabilitation Post Hip Fracture Study (HipERS)
Status: Enrolling
Updated:  12/31/1969
University of Maryland
2327
mi
from 98109
Baltimore, MD
Hip Fracture Exercise and Rehabilitation Post Hip Fracture Study
Feasibility of Extended Post-Acute Intervention for Hip Fracture Patients With Cognitive Limitations: Hip Fracture Exercise and Rehabilitation Post Hip Fracture Study (HipERS)
Status: Enrolling
Updated: 12/31/1969
University of Maryland
2327
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Intervention to Reduce Sedentary Time
Intervention to Reduce Sitting Time in Mild Cognitive Impairment
Status: Enrolling
Updated:  12/31/1969
University of Kansas Medical Center
1495
mi
from 98109
Kansas City, KA
Intervention to Reduce Sedentary Time
Intervention to Reduce Sitting Time in Mild Cognitive Impairment
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
1495
mi
from 98109
Kansas City, KA
Click here to add this to my saved trials
Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's Disease
Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Health
2275
mi
from 98109
Winston-Salem, NC
Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's Disease
Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Health
2275
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
COcoa Supplement and Multivitamin Outcomes Study for the Mind
COcoa Supplement and Multivitamin Outcomes Study-Mind
Status: Enrolling
Updated:  12/31/1969
Wake Forest School of Medicine
2279
mi
from 98109
Winston-Salem, NC
COcoa Supplement and Multivitamin Outcomes Study for the Mind
COcoa Supplement and Multivitamin Outcomes Study-Mind
Status: Enrolling
Updated: 12/31/1969
Wake Forest School of Medicine
2279
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated:  12/31/1969
Woodland International Research Group, Inc.
1782
mi
from 98109
Little Rock, AR
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Woodland International Research Group, Inc.
1782
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated:  12/31/1969
Woodland Research Northwest
1634
mi
from 98109
Rogers, AR
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Woodland Research Northwest
1634
mi
from 98109
Rogers, AR
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated:  12/31/1969
Alliance for Wellness dba Alliance for Research
977
mi
from 98109
Long Beach, CA
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Alliance for Wellness dba Alliance for Research
977
mi
from 98109
Long Beach, CA
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated:  12/31/1969
New Hope Clinical Research
2282
mi
from 98109
Charlotte, NC
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
New Hope Clinical Research
2282
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated:  12/31/1969
IPS Research Company
1522
mi
from 98109
Oklahoma City, OK
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
IPS Research Company
1522
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated:  12/31/1969
Cutting Edge Research Group
1518
mi
from 98109
Oklahoma City, OK
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Cutting Edge Research Group
1518
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated:  12/31/1969
Clinical Trials of Texas, Inc.
1779
mi
from 98109
San Antonio, TX
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Clinical Trials of Texas, Inc.
1779
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated:  12/31/1969
Road Runner Research
1774
mi
from 98109
San Antonio, TX
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Road Runner Research
1774
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated:  12/31/1969
Aspen Clinical Research, LLC
732
mi
from 98109
Orem, UT
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
A Phase 1, Single-dose, Sequential Cohort, Nonrandomized Crossover Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Oral Brexpiprazole in Children (6 to< 13 Years Old) With Central Nervous System Disorders
Status: Enrolling
Updated: 12/31/1969
Aspen Clinical Research, LLC
732
mi
from 98109
Orem, UT
Click here to add this to my saved trials
Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive Impairment
Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive Impairment
Status: Enrolling
Updated:  12/31/1969
Brickstone/Saint John Meadow
2162
mi
from 98109
Rochester, NY
Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive Impairment
Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive Impairment
Status: Enrolling
Updated: 12/31/1969
Brickstone/Saint John Meadow
2162
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive Impairment
Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive Impairment
Status: Enrolling
Updated:  12/31/1969
River Edge Manor
2161
mi
from 98109
Rochester, NY
Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive Impairment
Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive Impairment
Status: Enrolling
Updated: 12/31/1969
River Edge Manor
2161
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude.
Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude.
Status: Enrolling
Updated:  12/31/1969
UCSD Sleep Lab
1063
mi
from 98109
San Diego, CA
Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude.
Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude.
Status: Enrolling
Updated: 12/31/1969
UCSD Sleep Lab
1063
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Intervention Comparative Effectiveness for Adult Cognitive Training
Intervention Comparative Effectiveness for Adult Cognitive Training
Status: Enrolling
Updated:  12/31/1969
Florida State University
2328
mi
from 98109
Tallahassee, FL
Intervention Comparative Effectiveness for Adult Cognitive Training
Intervention Comparative Effectiveness for Adult Cognitive Training
Status: Enrolling
Updated: 12/31/1969
Florida State University
2328
mi
from 98109
Tallahassee, FL
Click here to add this to my saved trials
Prevention of Early Postoperative Decline
Prevention of Early Postoperative Decline
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
2485
mi
from 98109
Boston, MA
Prevention of Early Postoperative Decline
Prevention of Early Postoperative Decline
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Feasibility of an 8-week Tai Chi Chuan Intervention for Breast Cancer Survivors
Feasibility of an 8-week Tai Chi Chuan Intervention for Breast Cancer Survivors
Status: Enrolling
Updated:  12/31/1969
UNC Chapel Hill Program on Integrative Medicine
2338
mi
from 98109
Chapel Hill, NC
Feasibility of an 8-week Tai Chi Chuan Intervention for Breast Cancer Survivors
Feasibility of an 8-week Tai Chi Chuan Intervention for Breast Cancer Survivors
Status: Enrolling
Updated: 12/31/1969
UNC Chapel Hill Program on Integrative Medicine
2338
mi
from 98109
Chapel Hill, NC
Click here to add this to my saved trials
Administration Method of Cognitive Screening in Older Individuals With Hearing Loss
The Impact of Test Administration Method on Cognitive Screening Results in Older Individuals With Hearing Loss
Status: Enrolling
Updated:  12/31/1969
Hearing Aid Laboratory
1725
mi
from 98109
Evanston, IL
Administration Method of Cognitive Screening in Older Individuals With Hearing Loss
The Impact of Test Administration Method on Cognitive Screening Results in Older Individuals With Hearing Loss
Status: Enrolling
Updated: 12/31/1969
Hearing Aid Laboratory
1725
mi
from 98109
Evanston, IL
Click here to add this to my saved trials
Involving Family to Improve Communication in Primary Care
Involving Family to Improve Primary Care Visits for Cognitively Impaired Patients
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Community Physicians
2339
mi
from 98109
Aberdeen, MD
Involving Family to Improve Communication in Primary Care
Involving Family to Improve Primary Care Visits for Cognitively Impaired Patients
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Community Physicians
2339
mi
from 98109
Aberdeen, MD
Click here to add this to my saved trials
Involving Family to Improve Communication in Primary Care
Involving Family to Improve Primary Care Visits for Cognitively Impaired Patients
Status: Enrolling
Updated:  12/31/1969
Medstar Center for Successful Aging
2327
mi
from 98109
Baltimore, MD
Involving Family to Improve Communication in Primary Care
Involving Family to Improve Primary Care Visits for Cognitively Impaired Patients
Status: Enrolling
Updated: 12/31/1969
Medstar Center for Successful Aging
2327
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Involving Family to Improve Communication in Primary Care
Involving Family to Improve Primary Care Visits for Cognitively Impaired Patients
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Community Physicians
2302
mi
from 98109
Westminster, MD
Involving Family to Improve Communication in Primary Care
Involving Family to Improve Primary Care Visits for Cognitively Impaired Patients
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Community Physicians
2302
mi
from 98109
Westminster, MD
Click here to add this to my saved trials
Biomarker Levels as A Predictor of Concussion Severity OUTcomes (BlacOut)
Biomarker Levels as A Predictor of Concussion Severity OUTcomes (BlacOut)
Status: Enrolling
Updated:  12/31/1969
Regions Hospital
1399
mi
from 98109
Saint Paul, MN
Biomarker Levels as A Predictor of Concussion Severity OUTcomes (BlacOut)
Biomarker Levels as A Predictor of Concussion Severity OUTcomes (BlacOut)
Status: Enrolling
Updated: 12/31/1969
Regions Hospital
1399
mi
from 98109
Saint Paul, MN
Click here to add this to my saved trials
MIND Diet Intervention and Cognitive Decline
MIND Diet Intervention to Prevent Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Rush University
1730
mi
from 98109
Chicago, IL
MIND Diet Intervention and Cognitive Decline
MIND Diet Intervention to Prevent Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Rush University
1730
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
MIND Diet Intervention and Cognitive Decline
MIND Diet Intervention to Prevent Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Harvard School of Public Health
2484
mi
from 98109
Boston, MA
MIND Diet Intervention and Cognitive Decline
MIND Diet Intervention to Prevent Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Harvard School of Public Health
2484
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Status: Enrolling
Updated:  12/31/1969
US Army, Fort Benning
2212
mi
from 98109
Fort Benning, GA
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Status: Enrolling
Updated: 12/31/1969
US Army, Fort Benning
2212
mi
from 98109
Fort Benning, GA
Click here to add this to my saved trials
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health
2315
mi
from 98109
Bethesda, MD
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Click here to add this to my saved trials